Imperial Innovations Limited

Oregon Health & Science University

Mohammad Ali Ghatei

Stephen Robert Bloom

Caroline Jane Small

Roger D Cone

Michael Alexander Cowley

Andrew A Butler

Rachel Louise Batterham

Catherine Louise Dakin

Malcolm J Low

Stanley Moore

Malcolm James Duncan Low

Michael Cowley

Methods are disclosed for decreasing calorie intake, food intake, and appetite in a subject. The methods include peripherally administering a therapeutically effective amount of PYY or an agonist thereof to the subject, thereby decreasing the calorie intake of the subject.

Modification of feeding behavior

The present invention relates to compounds of formula (I); variants or derivatives thereof, or salts or solvates thereof. The present invention also relates to the use of such compounds to control appetite, feeding, food intake, energy expenditure and calorie intake, particularly in the treatment of obesity. 

Modified PYY (3-36) peptides and their effects on feeding behavior

Methods are disclosed for decreasing calorie intake, food intake, and appetite in a subject. The methods include peripherally administering PYY or an agonist thereof and GLP-1 or an agonist thereof to the subject, simultaneously or sequentially, thereby decreasing the calorie intake of the subject.

Modification of feeding behavior using PYY and GLP-1

The present invention relates to compositions and methods for use in the prevention or treatment of excess weight in a mammal. The compositions comprise oxyntomodulin which is shown to reduce food intake and/or increase energy expenditure.

Modification of feeding behaviour

Compositions and methods for use in the prevention or treatment of excess weight in a mammal have been developed. The compositions comprise oxyntomodulin which is shown to reduce food intake.

Growing community of inventors

London, United Kingdom

Mohammad Ali Ghatei